Literature DB >> 341172

Immunological changes in liver disease.

S Sherlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 341172      PMCID： PMC1543549     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  23 in total

1.  Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

Authors:  U Hopf; K H Meyer zum Büschenfelde; W Arnold
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

2.  Trigger factors and HL-A antigens in chronic active hepatitis.

Authors:  J Lindberg; A Lindholm; P Lundin; S Iwarson
Journal:  Br Med J       Date:  1975-10-11

3.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

4.  Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

Authors:  S W Schalm; W H Summerskill; G L Gitnick; L R Elveback
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

5.  Two immunologic reactions in the pathogenesis of hepatitis?

Authors:  F Paronetto; H Popper
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

6.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

7.  The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens.

Authors:  H C Thomas; C J Ryan; I S Benjamin; L H Blumgart; R N MacSween
Journal:  Gastroenterology       Date:  1976-07       Impact factor: 22.682

8.  Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.

Authors:  R J Dehoratius; C Henderson; R G Strickland
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

9.  Liver-cell-membrane autoantibody specific for inflammatory liver diseases.

Authors:  U Tage-Jensen; W Arnold; O Dietrichson; F Hardt; U Hopf; K H Meyer Zum Büschenfelde; J O Nielsen
Journal:  Br Med J       Date:  1977-01-22

10.  Studies on the specificity of smooth-muscle antibodies.

Authors:  P Andersen; J V Small; A Sobieszek
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330
View more
  4 in total

1.  The liver as a barrier against antigens in viral hepatitis infection.

Authors:  P R Lorenz
Journal:  Naturwissenschaften       Date:  1978-12

2.  Development of Hodgkin's disease in the course of liver cirrhosis and impaired monocyte function.

Authors:  M Dan; A Hassner; M Jedwab; S Shibolet
Journal:  Postgrad Med J       Date:  1984-07       Impact factor: 2.401

3.  Impaired monocyte function in liver cirrhosis.

Authors:  A Hassner; Y Kletter; D Shlag; M Yedvab; M Aronson; S Shibolet
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-18

4.  Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment.

Authors:  John P Gibbs; J Greg Slatter; Ogo Egbuna; Michelle Geller; Lisa Hamilton; Clapton S Dias; Ren Y Xu; Jessica Johnson; Scott M Wasserman; Maurice G Emery
Journal:  J Clin Pharmacol       Date:  2016-10-26       Impact factor: 3.126
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.